Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control. (March 2023)

• Record Type: Journal Article
• Authors: Julve, Josep; Genua, Idoia; Quifer-Rada, Paola; Yanes, Óscar; Barranco-Altirriba, Maria; Hernández, Marta; Junza, Alexandra; Capellades, Jordi; Granado-Casas, Minerva; Alonso, Núria; Castelblanco, Esmeralda; Mauricio, Didac
• Is Part Of: Diabetes research and clinical practice. Volume 197(2023)
• Publication Date: 2023-03
• Subjects: Translational research -- Impaired insulin signaling -- Fatty acids -- Lipid metabolism -- Type 1 diabetes; BMI body mass index -- CKD-EPI Chronic Kidney Disease Epidemiology Collaboration -- CVD cardiovascular disease -- DBP diastolic blood pressure -- eGFR estimated glomerular filtration rate -- FCs fold-changes -- HbA1c glycosylated hemoglobin -- HDL-C high-density lipoprotein cholesterol -- LDL-C low-density lipoprotein cholesterol -- PC phosphatidylcholines -- SBP systolic blood pressure -- SM sphingomyelin -- T1DM type 1 diabetes mellitus -- TG triglycerides; Diabetes -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462
• DOI: 10.1016/j.diabres.2023.110578
• Languages: English
• ISSNs: 0168-8227

Abstract

Abstract: Aims: To uncover novel candidate metabolomic and lipidomic biomarkers in newly-diagnosed type 1 diabetes (T1DM) after achieving optimal glucose control. Methods: Comprehensive lipidomic and metabolomic analysis was performed in serum of 12 adults with T1DM at onset and after achieving optimal glycemic control (HbA1c < 7 %) (after 2–6 months). Results: After intensive therapy, subjects (mean age 25.2 years, 58.3 % men) showed decreases in blood glucose (p < 0.001), HbA1c [11.5 % (9.2–13.4) to 6.2 % (5.2 – 6.7); p < 0.001] and changes in 51 identified lipids. Among these changes, we found that triglycerides (TG) containing medium chain fatty acids (TG45:0, TG47:1), sphingomyelins (SM) (SM(d18:2/20:0), SM42:4)), and phosphatidylcholines (PC) (PC(O-26:2), PC(O-30:0), PC(O-32:0), PC(O-42:6), PC(O-44:5), PC(O-38:3), PC(O-33:0), PC(O-46:8), PC(O-44:6), PC(O-40:3), PC(O-42:4), PC(O-46:7), PC(O-46:6), PC(O-44:5), PC(O-42:3), PC(O-44:4)) decreased; whereas PC(35:1), PC(37:1) and TG containing longer chain fatty acids (TG(52:1), TG(55:7), TG(51:2), TG(53:3), TG52:2), TG(53:2), TG(57:3), TG(61:3), TG(61:2) increased. Further, dihydro O-acylceramide (18:1/18:0/16:0), diacylglycerophosphoethanolamine (PE(34:1)), diacylglycerophosphoinositol (PI(38:6), and dihydrosphingomyelins (dihydroSM(36:0), dihydroSM(40:0), dihydroSM(41:0), dihydroSM(42:0)) increased. Uric acid, mannitol, and mannitol-1-acetate levels also increased. Conclusions: Our data uncovered potential favorable changes in the metabolism of glycerophospholipids, glycerolipids, and sphingolipids in new-onset T1DM after achieving optimal glycemic control. Further research on their potential role in developing diabetes-related complications is needed.